| 臺大學術典藏 |
2010 |
Pelvic skeletal metastasis of hepatocellular carcinoma with sarcomatous change: A case report
|
WEI-HSIN LIN; Lan T.-Y.; Hsueh Y.-T.; Chen C.-Y.; Yang R.-S.; Wu K. |
| 臺大學術典藏 |
2021-05-31T02:57:19Z |
Pelvic skeletal metastasis of hepatocellular carcinoma with sarcomatous change: A case report
|
Chen C.-Y.; Hsueh Y.-T.; Lan T.-Y.; Lin W.-H.; Wu K.; RONG-SEN YANG |
| 元智大學 |
2011-08 |
PEM Fuel Cell Diagnostic Tools, Chapter 10: Transparent cell, pp.209-230
|
Chun-Ying Hsu; Fangbor Weng |
| 國立臺灣科技大學 |
2018 |
PEM fuel cells of poly(2,5-benzimidazole) ABPBI membrane electrolytes doped with phosphoric acid and metal phosphates
|
Chiang Y.-C.; Tsai D.-S.; Liu Y.-H.; Chiang C.-W. |
| 元智大學 |
2020/10/19 |
PEM water electrolyzers with internal real-time sensing function
|
Chi-Yuan Lee; Chia-Hung Chen; Guo-Bin Jung; Yu-Xiang Zheng; Yi-Zhen Zeng |
| 元智大學 |
2020/10/19 |
PEM water electrolyzers with internal real-time sensing function
|
Chi-Yuan Lee; Chia-Hung Chen; Guo-Bin Jung; Yu-Xiang Zheng; Yi-Zhen Zeng |
| 元智大學 |
2015-12-11 |
PEM 水電解技術製超氧(O3)陽極製備法對性能之影響
|
余浚瑋; 葉佳鎮; 馬嘉慶; Guo-Bin Jung |
| 元智大學 |
2016-11-27 |
PEM 水電解製超氧技術中陽極端電解板之抗蝕層組成研究
|
李哲宇; 馬嘉慶; 余浚瑋; 連傳興; Guo-Bin Jung |
| 元智大學 |
2015-12-11 |
PEM 水電解製超氧技術中電解板之陽極觸媒分析
|
馬嘉慶; 陳杞文; 葉佳鎮; 林政隆; Guo-Bin Jung |
| 元智大學 |
2013 |
PEM 水電解製超氧發生器之研究
|
呂宥霆; You-Ting Lu |
| 元智大學 |
2017-12-01 |
PEM 水電解陽極端中添加碳材對性能之影響
|
Guo-Bin Jung; 林政隆; 余浚偉; 李哲宇; 甘旻諭 |
| 元智大學 |
2017-12-01 |
PEM 水電解陽極端中添加碳材對性能之影響
|
Guo-Bin Jung; 林政隆; 余浚偉; 李哲宇; 甘旻諭 |
| 臺大學術典藏 |
2005-07-31 |
PEM 燃料電池動態響應時間常數之理論與實驗研究(1/3)
|
陳發林; 陳發林 |
| 國立臺灣大學 |
2005-07-31 |
PEM 燃料電池動態響應時間常數之理論與實驗研究(1/3)
|
陳發林 |
| 輔英科技大學 |
2005-05-01 |
PeMADS6, a GLOBOSA/PISTILLATA-like Gene in Phalaenopsis equestris Involved in Petaloid Formation, and Correlated with Flower Longevity and Ovary Development
|
Tsai, W. C.; Lee, P. F.;Chen, H. I. ; Hsiao, Y. Y.; Wei, W. J. ; Pan, Z. J. ; Chuang, M. H. ;Kuoh, C. S. ;Chen , W. H. ; Chen, H. H. |
| 國立成功大學 |
2005-07 |
PeMADS6, a GLOBOSA/PISTILLATA-like gene in Phalaenopsis equestris involved in petaloid formation, and correlated with flower longevity and ovary development
|
Tsai, Wen-Chieh; Lee, Pei-Fang; Chen, Hong-Ie; Hsiao, Yu-Yun; Wei, Wan-Ju; Pan, Zhao-Jun; Chuang, Ming-Hsiang; Kuoh, Chang-Sheng; Chen, Wen-Huei; Chen, Hong-Hwa |
| 國立臺灣大學 |
2015 |
Pembrolizumab (pembro; MK-3475) plus platinum doublet chemotherapy (PDC) as front-line therapy for advanced non-small cell lung cancer (NSCLC): KEYNOTE-021 Cohorts A and C.
|
Papadimitrakopoulou, Vassiliki; Patnaik, Amita; Borghaei, Hossein; Stevenson, James; Gandhi, Leena; Gubens, Matthew A.; Yang, James Chih-Hsin; Sequist, Lecia V.; Ge, Joy Yang; Bourque, Jennifer; Bachman, Robert D.; Im, Ellie; Gadgeel, Shirish M.; 楊志新 |
| 臺大學術典藏 |
2021-03-09T06:45:59Z |
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
|
Burtness B.;Harrington K.J.;Greil R.;Souli?Res D.;Tahara M.;De Castro G.;Jr, Psyrri A.;Bast? N.;Neupane P.;Bratland ?.;Fuereder T.;Hughes B.G.M.;Mes?A R.;Ngamphaiboon N.;Rordorf T.;Wan Ishak W.Z.;Ruey-Long Hong;Gonz?Lez Mendoza R.;Roy A.;Zhang Y.;Gumuscu B.;Cheng J.D.;Jin F.;Rischin D.;Lerzo G.;Tatangelo M.;Varela M.;Zarba J.J.;Boyer M.;Gan H.;Gao B.;Hughes B.;Mallesara G.;Taylor A.;Burian M.;Barrios C.H.;De Castro Junior D.O.;Castro G.;Franke F.A.;Girotto G.;Lima I.P.F.;Nicolau U.R.;Pinto G.D.J.;Santos L.;Victorino A.-P.;Chua N.;Couture F.;Gregg R.;Hansen A.;Hilton J.;Mccarthy J.;Soulieres D.;Ascui R.;Gonzalez P.;Villanueva L.;Torregroza M.;Zambrano A.;Holeckova P.;Kral Z.;Melichar B.;Prausova J.;Vosmik M.;Andersen M.;Gyldenkerne N.;Jurgens H.;Putnik K.;Reinikainen P.;Gruenwald V.;Laban S.;Aravantinos G.;Boukovinas I.;Georgoulias V.;Kwong D.;Al-Farhat Y.;Csoszi T.;Erfan J.;Horvai G.;Landherr L.;Remenar E.;Ruzsa A.;Szota J.;Billan S.;Gluck I.;Gutfeld O.;Popovtzer A.;Benasso M.;Bui S.;Ferrari V.;Licitra L.;Nole F.;Fujii T.;Fujimoto Y.;Hanai N.;Hara H.;Matsumoto K.;Mitsugi K.;Monden N.;Nakayama M.;Okami K.;Oridate N.;Shiga K.;Shimizu Y.;Sugasawa M.;Takahashi M.;Takahashi S.;Tanaka K.;Ueda T.;Yamaguchi H.;Yamazaki T.;Yasumatsu R.;Yokota T.;Yoshizaki T.;Kudaba I.;Stara Z.;Cheah S.K.;Aguilar Ponce J.;Gonzalez Mendoza R.;Hernandez Hernandez C.;Medina Soto F.;Buter J.;Hoeben A.;Oosting S.;Suijkerbuijk K.;Bratland A.;Brydoey M.;Alvarez R.;Mas L.;Caguioa P.;Querol J.;Regala E.E.;Tamayo M.B.;Villegas E.M.;Kawecki A.;Karpenko A.;Klochikhin A.;Smolin A.;Zarubenkov O.;Goh B.C.;Cohen G.;Du Toit J.;Jordaan C.;Landers G.;Ruff P.;Szpak W.;Tabane N.;Brana I.;Iglesias Docampo L.;Lavernia J.;Mesia R.;Abel E.;Muratidu V.;Nielsen N.;Cristina V.;Rothschild S.;Wang H.-M.;Yang M.-H.;Yeh S.-P.;Yen C.-J.;Soparattanapaisarn N.;Sriuranpong V.;Aksoy S.;Cicin I.;Ekenel M.;Harputluoglu H.;Ozyilkan O.;Harrington K.;Agarwala S.;Ali H.;Alter R.;Anderson D.;Bruce J.;Campbell N.;Conde M.;Deeken J.;Edenfield W.;Feldman L.;Gaughan E.;Goueli B.;Halmos B.;Hegde U.;Hunis B.;Jotte R.;Karnad A.;Khan S.;Laudi N.;Laux D.;Martincic D.;Mccune S.;Mcgaughey D.;Misiukiewicz K.;Mulford D.;Nadler E.;Nunnink J.;Ohr J.;O'Malley M.;Patson B.;Paul D.;Popa E.;Powell S.;Redman R.;Rella V.;Rocha Lima C.;Sivapiragasam A.;Su Y.;Sukari A.;Wong S.;Yilmaz E.;Yorio J.; Burtness B.; Harrington K.J.; Greil R.; Souli?res D.; Tahara M.; de Castro G.; Jr, Psyrri A.; Bast? N.; Neupane P.; Bratland ?.; Fuereder T.; Hughes B.G.M.; Mes?a R.; Ngamphaiboon N.; Rordorf T.; Wan Ishak W.Z.; RUEY-LONG HONG; Gonz?lez Mendoza R.; Roy A.; Zhang Y.; Gumuscu B.; Cheng J.D.; Jin F.; Rischin D.; Lerzo G.; Tatangelo M.; Varela M.; Zarba J.J.; Boyer M.; Gan H.; Gao B.; Hughes B.; Mallesara G.; Taylor A.; Burian M.; Barrios C.H.; de Castro Junior D.O.; Castro G.; Franke F.A.; Girotto G.; Lima I.P.F.; Nicolau U.R.; Pinto G.D.J.; Santos L.; Victorino A.-P.; Chua N.; Couture F.; Gregg R.; Hansen A.; Hilton J.; McCarthy J.; Soulieres D.; Ascui R.; Gonzalez P.; Villanueva L.; Torregroza M.; Zambrano A.; Holeckova P.; Kral Z.; Melichar B.; Prausova J.; Vosmik M.; Andersen M.; Gyldenkerne N.; Jurgens H.; Putnik K.; Reinikainen P.; Gruenwald V.; Laban S.; Aravantinos G.; Boukovinas I.; Georgoulias V.; Kwong D.; Al-Farhat Y.; Csoszi T.; Erfan J.; Horvai G.; Landherr L.; Remenar E.; Ruzsa A.; Szota J.; Billan S.; Gluck I.; Gutfeld O.; Popovtzer A.; Benasso M.; Bui S.; Ferrari V.; Licitra L.; Nole F.; Fujii T.; Fujimoto Y.; Hanai N.; Hara H.; Matsumoto K.; Mitsugi K.; Monden N.; Nakayama M.; Okami K.; Oridate N.; Shiga K.; Shimizu Y.; Sugasawa M.; Takahashi M.; Takahashi S.; Tanaka K.; Ueda T.; Yamaguchi H.; Yamazaki T.; Yasumatsu R.; Yokota T.; Yoshizaki T.; Kudaba I.; Stara Z.; Cheah S.K.; Aguilar Ponce J.; Gonzalez Mendoza R.; Hernandez Hernandez C.; Medina Soto F.; Buter J.; Hoeben A.; Oosting S.; Suijkerbuijk K.; Bratland A.; Brydoey M.; Alvarez R.; Mas L.; Caguioa P.; Querol J.; Regala E.E.; Tamayo M.B.; Villegas E.M.; Kawecki A.; Karpenko A.; Klochikhin A.; Smolin A.; Zarubenkov O.; Goh B.C.; Cohen G.; du Toit J.; Jordaan C.; Landers G.; Ruff P.; Szpak W.; Tabane N.; Brana I.; Iglesias Docampo L.; Lavernia J.; Mesia R.; Abel E.; Muratidu V.; Nielsen N.; Cristina V.; Rothschild S.; Wang H.-M.; Yang M.-H.; Yeh S.-P.; Yen C.-J.; Soparattanapaisarn N.; Sriuranpong V.; Aksoy S.; Cicin I.; Ekenel M.; Harputluoglu H.; Ozyilkan O.; Harrington K.; Agarwala S.; Ali H.; Alter R.; Anderson D.; Bruce J.; Campbell N.; Conde M.; Deeken J.; Edenfield W.; Feldman L.; Gaughan E.; Goueli B.; Halmos B.; Hegde U.; Hunis B.; Jotte R.; Karnad A.; Khan S.; Laudi N.; Laux D.; Martincic D.; McCune S.; McGaughey D.; Misiukiewicz K.; Mulford D.; Nadler E.; Nunnink J.; Ohr J.; O'Malley M.; Patson B.; Paul D.; Popa E.; Powell S.; Redman R.; Rella V.; Rocha Lima C.; Sivapiragasam A.; Su Y.; Sukari A.; Wong S.; Yilmaz E.; Yorio J. |
| 國立成功大學 |
2022-11 |
Pembrolizumab and Chemotherapy Combination Prolonged Progression-Free Survival in Patients with NSCLC with High PD-L1 Expression and Low Neutrophil-to-Lymphocyte Ratio
|
Tsai;Jeng-Shiuan;Wei;Sheng-Huan;Chen;Chian-Wei;Yang;Szu-Chun;Tseng;Yau-Lin;Su;Po-Lan;Lin;Chien-Chung;Su;Wu-Chou |
| 臺大學術典藏 |
2020-05-26T09:26:25Z |
Pembrolizumab and platinum-based chemotherapy as first-line therapy for advanced non?�small-cell lung cancer: Phase 1 cohorts from the KEYNOTE-021 study
|
Papadimitrakopoulou V.;Raftopoulos H;Saraf S;Bachman R;Sequist L.V;Chih-Hsin Yang;Hauke R;Gubens M;Villaruz L.C;Patnaik A;Borghaei H;Gandhi L;Langer C.J;Stevenson J.P;Gadgeel S.M; Gadgeel S.M; Stevenson J.P; Langer C.J; Gandhi L; Borghaei H; Patnaik A; Villaruz L.C; Gubens M; Hauke R; CHIH-HSIN YANG; Sequist L.V; Bachman R; Saraf S; Raftopoulos H; Papadimitrakopoulou V. |
| 臺大學術典藏 |
2022-02-21T02:04:35Z |
Pembrolizumab as second-line therapy for advanced hepatocellular carcinoma: A subgroup analysis of asian patients in the phase 3 KEYNOTE-240 trial
|
Kudo M.; Lim H.Y.; ANN-LII CHENG; Chao Y.; Yau T.; Ogasawara S.; Kurosaki M.; Morimoto N.; Ohkawa K.; Yamashita T.; Lee K.-H.; Chen E.; Siegel A.B.; Ryoo B.-Y. |
| 臺大學術典藏 |
2021-08-31T06:29:19Z |
Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYnote-240: A Randomized, Double-Blind, Phase III Trial
|
Finn R.S.; Ryoo B.-Y.; Merle P.; Kudo M.; Bouattour M.; Lim H.Y.; Breder V.; Edeline J.; Chao Y.; Ogasawara S.; Yau T.; Garrido M.; Chan S.L.; Knox J.; Daniele B.; Ebbinghaus S.W.; Chen E.; Siegel A.B.; Zhu A.X.; ANN-LII CHENG; KEYnote-240 investigators |
| 臺大學術典藏 |
2020-05-25T07:35:18Z |
Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial
|
McRee A.J; Chia-Chi Lin; Pathiraja K; Lunceford J; Emancipator K; Juco J; Koshiji M; Bang Y.-J.; Bang Y.-J.;Koshiji M;Juco J;Emancipator K;Lunceford J;Pathiraja K;Chia-Chi Lin;McRee A.J;Burtness B;Le D.T;Golan T;Eder J.P;Gupta S;Catenacci D;Geva R;Shankaran V;Chung H.C;Muro K; Muro K; Chung H.C; Shankaran V; Geva R; Catenacci D; Gupta S; Eder J.P; Golan T; Le D.T; Burtness B |
| 臺大學術典藏 |
2021-03-09T06:46:02Z |
Pembrolizumab for the treatment of advanced salivary gland carcinoma
|
Cohen R.B.;Delord J.-P.;Doi T.;Piha-Paul S.A.;Liu S.V.;Gilbert J.;Algazi A.P.;Damian S.;Ruey-Long Hong;Le Tourneau C.;Day D.;Varga A.;Elez E.;Wallmark J.;Saraf S.;Thanigaimani P.;Cheng J.;Keam B.; Cohen R.B.; Delord J.-P.; Doi T.; Piha-Paul S.A.; Liu S.V.; Gilbert J.; Algazi A.P.; Damian S.; RUEY-LONG HONG; Le Tourneau C.; Day D.; Varga A.; Elez E.; Wallmark J.; Saraf S.; Thanigaimani P.; Cheng J.; Keam B. |
| 臺大學術典藏 |
2021-02-18T01:45:22Z |
Pembrolizumab for the treatment of programmed death�Vligand 1?positive advanced carcinoid or pancreatic neuroendocrine tumors: Results from the KEYNOTE-028 study
|
Mehnert J.M.;Bergsland E.;O??Neil B.H.;Santoro A.;Schellens J.H.M.;Cohen R.B.;Doi T.;Ott P.A.;Pishvaian M.J.;Puzanov I.;Aung K.L.;Chiun Hsu;Le Tourneau C.;Hollebecque A.;?Lez E.;Tamura K.;Gould M.;Yang P.;Stein K.;Piha-Paul S.A.; Mehnert J.M.; Bergsland E.; O��Neil B.H.; Santoro A.; Schellens J.H.M.; Cohen R.B.; Doi T.; Ott P.A.; Pishvaian M.J.; Puzanov I.; Aung K.L.; Chiun Hsu; Le Tourneau C.; Hollebecque A.; ?lez E.; Tamura K.; Gould M.; Yang P.; Stein K.; Piha-Paul S.A. |
